Published · Updated · United States
HIPAAHigh severityEnforcement action
New York, Connecticut AGs settle with Boston Children’s Health Physicians and XTIUM for $2.7 million
New York and Connecticut AGs settled with BCHP and XTIUM over a 2024 breach affecting 890,000 people, imposing a $4 million penalty with $2.7 million payable now.
1 source · $4M penalty · New York Attorney General and Connecticut Attorney General

What happened
- Boston Children’s Health Physicians and its IT provider XTIUM settled an investigation by the New York and Connecticut Attorneys General into a August 2024 breach that exposed data of nearly 890,000 individuals.
- The breach stemmed from XTIUM’s insecure remote‑access tool and inadequate logging, allowing attackers to exfiltrate unencrypted patient billing records.
- The settlement includes a $4 million penalty, $2.7 million of which is payable to the states, with $1.3 million suspended pending compliance.
- Both parties must implement specific cybersecurity measures, and the suspended amount will be triggered if they fail to meet them.
Why it matters
Healthcare organisations that rely on third‑party IT managers must audit remote‑access configurations, enforce least‑privilege accounts and ensure robust logging to avoid similar enforcement actions.
Business impact
Non‑compliance could result in multi‑million‑dollar penalties and mandatory security upgrades, affecting budgets and operational timelines.
Drafted automatically from the sources below. How we write summaries
Does this summary seem wrong?What to check
Secure remote‑access toolsHigh priority
Apply all recommended security settings and restrict administrative privileges.
Implement comprehensive logging and monitoringHigh priority
Enable continuous audit trails for all privileged access and remote sessions.
Enforce least‑privilege principlesHigh priority
Remove shared admin accounts and limit permissions to only what is necessary.
Segment networksMedium priority
Isolate critical patient data systems from other IT environments.
Discussion
No comments yet. Start the discussion.